Guardian Pharmacy Services (NYSE:GRDN) Raised to Buy at Wall Street Zen

Key Points

• Wall Street Zen upgraded Guardian Pharmacy Services from “hold” to “buy.” Overall, nine analysts rate the stock Buy and one rates it Hold, with a consensus “Moderate Buy” rating and an average price target of $45.57.
• The company beat quarterly expectations, reporting EPS of $0.33 versus the $0.31 consensus and revenue of $371.07 million versus an estimated $365.76 million.
• Shares opened at $49.56, near their 52-week high of $50.58; the stock’s 50-day and 200-day moving averages were $42.48 and $38.78, respectively.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a report released on Saturday, Wall Street Zen reports.

Several other research analysts also recently weighed in on the stock. KeyCorp started coverage on shares of Guardian Pharmacy Services in a research report on Tuesday, September 22nd. They issued an "overweight" rating and a $52.00 target price on the stock. Weiss Ratings upgraded shares of Guardian Pharmacy Services from a "buy (b-)" rating to a "buy (b)" rating in a research report on Monday. Oppenheimer raised their price objective on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an "outperform" rating in a research note on Friday, August 7th. Finally, Truist Financial raised their price objective on shares of Guardian Pharmacy Services from $47.00 to $51.00 and gave the stock a "buy" rating in a research note on Monday, September 21st. Nine equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $45.57.

Guardian Pharmacy Services Stock Up 0.4%

NYSE:GRDN opened at $49.56 on Friday. The stock has a fifty day simple moving average of $42.48 and a 200 day simple moving average of $38.78. The firm has a market capitalization of $3.14 billion, a price-to-earnings ratio of 42.36, a price-to-earnings-growth ratio of 2.58 and a beta of 0.06. Guardian Pharmacy Services has a 1-year low of $26.34 and a 1-year high of $50.58.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.02. The firm had revenue of $371.07 million for the quarter, compared to the consensus estimate of $365.76 million. Guardian Pharmacy Services had a return on equity of 30.29% and a net margin of 5.13%. Equities analysts predict that Guardian Pharmacy Services will post 1.18 earnings per share for the current year.

Institutional Investors Weigh In On Guardian Pharmacy Services

A number of institutional investors have recently bought and sold shares of the business. Nisa Investment Advisors LLC increased its holdings in shares of Guardian Pharmacy Services by 53.5% in the 3rd quarter. Nisa Investment Advisors LLC now owns 1,050 shares of the company's stock valued at $43,000 after purchasing an additional 366 shares during the period. State of Alaska Department of Revenue boosted its holdings in shares of Guardian Pharmacy Services by 105.9% during the third quarter. State of Alaska Department of Revenue now owns 2,390 shares of the company's stock worth $97,000 after purchasing an additional 1,229 shares during the period. Voya Investment Management LLC acquired a new stake in shares of Guardian Pharmacy Services during the third quarter worth approximately $238,000. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in shares of Guardian Pharmacy Services during the second quarter worth approximately $335,000. Finally, Arizona State Retirement System grew its position in Guardian Pharmacy Services by 53.0% during the second quarter. Arizona State Retirement System now owns 8,393 shares of the company's stock valued at $351,000 after purchasing an additional 2,907 shares in the last quarter.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc. provides pharmacy services to people living in long-term care and residential care settings. Its customers include assisted living and skilled nursing communities, behavioral health facilities, and other group-living providers. The company supplies prescription medications and offers medication packaging, delivery, consulting, and clinical support. Its services are designed to help care providers manage residents' medication needs and support continuity of care. Founded in 2004, Guardian operates a network of pharmacies serving communities across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.